The DOI matches its Crossref record; 85 of the 86 references it cites were found in a registry or an index.
Cerebrovascular disease, beta-amyloid, and cognition in aging
Open accessAbstract
The present study evaluated cerebrovascular disease (CVD), β-amyloid (Aβ), and cognition in clinically normal elderly adults. Fifty-four participants underwent magnetic resonance imaging (MRI), Pittsburgh compound B (PIB)-positron emission tomography (PET) imaging, and neuropsychological evaluation. High white matter hyperintensity burden and/or presence of infarct defined CVD status (CVD-: n = 27; CVD+: n = 27). PIB-positron emission tomography ratios of Aβ deposition were extracted using Logan plotting (cerebellar reference). Presence of high levels of Aβ in prespecified regions determined PIB status (PIB-: n = 33; PIB+: n = 21). Executive functioning and episodic memory were measured using composite scales. CVD and Aβ, defined as dichotomous or continuous variables, were unrelated to one another. CVD+ participants showed lower executive functioning (p = 0.001) when compared with CVD- individuals. Neither PIB status nor amount of Aβ affected cognition (ps ≥ 0.45), and there was no statistical interaction between CVD and PIB on either cognitive measure. Within this spectrum of normal aging CVD and Aβ aggregation appear to be independent processes with CVD primarily affecting cognition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the Aβ plaques may be found in 35% of cognitively healthy individuals above the age of 60 [290]”
From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [290]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Faul, F., Erdfelder, E., Lang, A.-G., & Buchner, A. (2007) · Behavior Research Methods · doi:10.3758/bf03193146 · Cited by 65,971
Tzourio-Mazoyer, N., Landeau, B., Papathanassiou, D., Crivello, F., Etard, O., Delcroix, N., Mazoyer, B., & Joliot, M. (2002) · NeuroImage · doi:10.1006/nimg.2001.0978 · Cited by 16,319
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
Frontal-subcortical circuits and human behavior
Cummings, J. L. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540080076020 · Cited by 2,262
Observations on the brains of demented old people
Tomlinson, B. E., Blessed, G., & Roth, M. (1970) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(70)90063-8 · Cited by 2,084
Mixed brain pathologies account for most dementia cases in community-dwelling older persons
Schneider, J. A., Arvanitakis, Z., Bang, W., & Bennett, D. A. (2007) · Neurology · doi:10.1212/01.wnl.0000271090.28148.24 · Cited by 1,992
Pendlebury, S. T., & Rothwell, P. M. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70236-4 · Cited by 1,853
Brain Infarction and the Clinical Expression of Alzheimer Disease<subtitle>The Nun Study</subtitle>
Snowdon, D. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540340047031 · Cited by 1,590
Cited by
Sorted by citations
Scheltens, P., Blennow, K., Breteler, M. M. B., de Strooper, B., Frisoni, G. B., Salloway, S., & Van der Flier, W. M. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01124-1 · Cited by 3,125
Ageing, Cellular Senescence and Neurodegenerative Disease
Kritsilis, M., V. Rizou, S., Koutsoudaki, P. N., Evangelou, K., Gorgoulis, V. G., & Papadopoulos, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102937 · Cited by 448
“Interestingly, the Aβ plaques may be found in 35% of cognitively healthy individuals above the age of 60 [290] and the Aβ load, which has been our main target, correlates better with age than disease severity in AD [291–293], casting doubt on the amyloid hypothesis.”
Chételat, G., Joie, R. L., Villain, N., Perrotin, A., Sayette, V. D. L., Eustache, F., & Vandenberghe, R. R. (2013) · NeuroImage Clinical · doi:10.1016/j.nicl.2013.02.006 · Cited by 363
Vulnerable Neural Systems and the Borderland of Brain Aging and Neurodegeneration
Jagust, W. J. (2013) · Neuron · doi:10.1016/j.neuron.2013.01.002 · Cited by 335
Self-citationVascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly
Vemuri, P., Lesnick, T. G., Przybelski, S. A., Knopman, D. S., Preboske, G. M., Kantarci, K., Raman, M. R., Machulda, M. M., Mielke, M. M., Lowe, V. J., et al. (2015) · Brain · doi:10.1093/brain/awu393 · Cited by 299
Associations Between Serum Cholesterol Levels and Cerebral Amyloidosis
Reed, B., Villeneuve, S., Mack, W., DeCarli, C., Chui, H. C., & Jagust, W. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.5390 · Cited by 267
Self-citationRisk Factors for β-Amyloid Deposition in Healthy Aging: Vascular and Genetic Effects
Rodrigue, K. M., Rieck, J. R., Kennedy, K. M., Devous, M. D., Diaz-Arrastia, R., & Park, D. C. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.1342 · Cited by 249
Rabin, J. S., Schultz, A. P., Hedden, T., Viswanathan, A., Marshall, G. A., Kilpatrick, E., Klein, H., Buckley, R. F., Yang, H.-S., Properzi, M., et al. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.1123 · Cited by 221
Hedden, T., Mormino, E. C., Amariglio, R. E., Younger, A. P., Schultz, A. P., Becker, J. A., Buckner, R. L., Johnson, K. A., Sperling, R. A., & Rentz, D. M. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.2462-12.2012 · Cited by 182
White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer’s disease
Araque Caballero, M. Á., Suárez-Calvet, M., Duering, M., Franzmeier, N., Benzinger, T., Fagan, A. M., Bateman, R. J., Jack, C. R., Levin, J., Dichgans, M., et al. (2018) · Brain · doi:10.1093/brain/awy229 · Cited by 184
“, 2017) and worse cognitive decline (Lo et al., 2012; Marchant et al., 2012; Vemuri et al., 2015).”
Self-citationSPECT and PET imaging in Alzheimer’s disease
Valotassiou, V., Malamitsi, J., Papatriantafyllou, J., Dardiotis, E., Tsougos, I., Psimadas, D., Alexiou, S., Hadjigeorgiou, G., & Georgoulias, P. (2018) · Annals of Nuclear Medicine · doi:10.1007/s12149-018-1292-6 · Cited by 169
Wirth, M., Villeneuve, S., Haase, C. M., Madison, C. M., Oh, H., Landau, S. M., Rabinovici, G. D., & Jagust, W. J. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.4013 · Cited by 171
Self-citationGurol, M. E., Viswanathan, A., Gidicsin, C. M., Hedden, T., Martínez‐Ramírez, S., Dumas, A. P., Vashkevich, A., Ayres, A. M., Auriel, E., van Etten, E. S., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23830 · Cited by 160
Vascular burden and Alzheimer disease pathologic progression
Lo, R. Y., Jagust, W. J., Weiner, M., Aisen, P., Weiner, M., Aisen, P., Petersen, R., Jack, C. R., Jagust, W., Trojanowki, J. Q., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e31826c1b9d · Cited by 156
Self-citationThe diagnostic value of FDG and amyloid PET in Alzheimer’s disease—A systematic review
Rice, L., & Bisdas, S. (2017) · European Journal of Radiology · doi:10.1016/j.ejrad.2017.07.014 · Cited by 156
Associations between amyloid β and white matter hyperintensities: A systematic review
Roseborough, A. D., Ramirez, J., Black, S. E., & Edwards, J. D. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2017.01.026 · Cited by 139
White matter hyperintensities across the adult lifespan: Relation to age, Aβ load, and cognition
Garnier-Crussard, A., Bougacha, S., Wirth, M., André, C., Delarue, M., Landeau, B., Mézenge, F., Kuhn, E., Gonneaud, J., Chocat, A., et al. (2020) · Alzheimer's Research & Therapy · doi:10.1186/s13195-020-00669-4 · Cited by 130
Wirth, M., Haase, C. M., Villeneuve, S., Vogel, J. W., & Jagust, W. J. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.02.015 · Cited by 138
Self-citationClinical and imaging features of mixed Alzheimer and vascular pathologies
Chui, H. C., & Ramirez-Gomez, L. (2015) · Alzheimer's Research & Therapy · doi:10.1186/s13195-015-0104-7 · Cited by 124
Self-citationThe aging brain and cognition: contribution of vascular injury and aβ to mild cognitive dysfunction
Marchant, N. L., Reed, B. R., Sanossian, N., Madison, C. M., Kriger, S., Dhada, R., Mack, W. J., DeCarli, C., Weiner, M. W., Mungas, D. M., et al. (2013) · JAMA Neurology · doi:10.1001/2013.jamaneurol.405 · Cited by 106
Self-citationWhy could meditation practice help promote mental health and well-being in aging?
Chételat, G., Antoine Lutz, A., Arenaza‐Urquijo, E. M., Collette, F., Klimecki, O., & Marchant, N. L. (2018) · Alzheimer s Research & Therapy · doi:10.1186/s13195-018-0388-5 · Cited by 108
Self-citationMetformin Facilitates Amyloid-β Generation by β- and γ -Secretases via Autophagy Activation
Son, S. M., Shin, H., Byun, J., Kook, S. Y., Moon, M., Chang, Y. J., & Mook‐Jung, I. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151200 · Cited by 106
Perneczky, R., Kempermann, G., Korczyn, A. D., Matthews, F. E., Ikram, M. A., Scarmeas, N., Chételat, G., Stern, Y., & Ewers, M. (2019) · BMC Medicine · doi:10.1186/s12916-019-1283-z · Cited by 114
Lee, M. J., Seo, S. W., Na, D. L., Kim, C., Park, J. H., Kim, G. H., Kim, C. H., Noh, Y., Cho, H., Kim, H. J., et al. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.4506 · Cited by 105
Self-citationMedical Comorbidity in Alzheimer’s Disease: A Nested Case-Control Study
Wang, J., Wu, Y.-J., Tee, B. L., & Lo, R. Y. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170786 · Cited by 107
Association of Serum Docosahexaenoic Acid With Cerebral Amyloidosis
Yassine, H. N., Feng, Q., Azizkhanian, I., Rawat, V., Castor, K., Fonteh, A. N., Harrington, M. G., Zheng, L., Reed, B. R., DeCarli, C., et al. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.1924 · Cited by 94
Self-citationKandel, B. M., Avants, B., Gee, J. C., McMillan, C. T., Erus, G., Doshi, J. J., Davatzikos, C. A., Wolk, D. A., & Initiative, A. D. N. (2016) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2016.03.001 · Cited by 98
Vascular risk and Aβ interact to reduce cortical thickness in AD vulnerable brain regions
Villeneuve, S., Reed, B., Madison, C. M., Wirth, M., Marchant, N. L., Kriger, S., Mack, W. J., Sanossian, N., DeCarli, C. S., Chui, H. C., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000550 · Cited by 93
Self-citationPark, J., Seo, S. W., Kim, C., Kim, S. H., Kim, G. H., Kim, S. T., Jeon, S., Lee, J. M., Oh, S. J., Kim, J. S., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.06.026 · Cited by 83
Self-citationImaging the role of blood–brain barrier disruption in normal cognitive ageing
Verheggen, I. C. M., de Jong, J. J. A., van Boxtel, M. P. J., Postma, A. A., Jansen, J. F. A., Verhey, F. R. J., & Backes, W. H. (2020) · GeroScience · doi:10.1007/s11357-020-00282-1 · Cited by 85
Clark, L. R., Racine, A. M., Koscik, R. L., Okonkwo, O. C., Engelman, C. D., Carlsson, C. M., Asthana, S., Bendlin, B. B., Chappell, R. J., Nicholas, C. R. N., et al. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.12.009 · Cited by 81
Tract-specific white matter hyperintensities disrupt neural network function in Alzheimer’s disease
Taylor, A. N. W., Kambeitz-Ilankovic, L., Gesierich, B., Simon-Vermot, L., Franzmeier, N., Araque Caballero, M. Á., Müller, S., Hesheng, L., Ertl-Wagner, B., Bürger, K., et al. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.06.2358 · Cited by 73
Self-citationCoronary risk correlates with cerebral amyloid deposition
Reed, B., Marchant, N. L., Jagust, W. J., DeCarli, C. S., Mack, W. J., & Chui, H. C. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.10.002 · Cited by 74
Self-citationCerebral white matter lesions – associations with Aβ isoforms and amyloid PET
van Westen, D., Lindqvist, D., Blennow, K., Minthon, L., Nägga, K., Stomrud, E., Zetterberg, H., & Hansson, O. (2016) · Scientific Reports · doi:10.1038/srep20709 · Cited by 66
Relative impact of amyloid-β, lacunes, and downstream imaging markers on cognitive trajectories.
Kim, H., Yang, J.-J., Kwon, H., Kim, C., Lee, J., Chun, P., Kim, Y., Jung, N.-Y., Chin, J., Kim, S., et al. (2016) · Brain : a journal of neurology · doi:10.1093/brain/aww148 · Cited by 64
Self-citationEffects of amyloid and vascular markers on cognitive decline in subcortical vascular dementia
Ye, B. S., Seo, S. W., Kim, J.-H., Kim, G. H., Cho, H., Noh, Y., Kim, H. J., Yoon, C. W., Woo, S.-Y., Kim, S. H., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000002097 · Cited by 67
Self-citationWhite Matter Hyperintensities as Early and Independent Predictors of Alzheimer's Disease Risk
Mortamais, M., Artéro, S., & Ritchie, K. A. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141473 · Cited by 69
Cerebrovascular Disease, Amyloid Plaques, and Dementia
Liu, W., Wong, A., Law, A. C. K., & Mok, V. (2015) · Stroke · doi:10.1161/strokeaha.114.006571 · Cited by 71
Advances in MRI Biomarkers for the Diagnosis of Alzheimer’s Disease
Kehoe, E. G., McNulty, J. P., Mullins, P. G., & Bokde, A. L. W. (2014) · Biomarkers in Medicine · doi:10.2217/bmm.14.42 · Cited by 70
18F-florbetaben Aβ imaging in mild cognitive impairment
Ong, K. T., Villemagne, V. L., Bahar‐Fuchs, A., Lamb, F., Chételat, G., Raniga, P., Mulligan, R. S., Salvado, O., Pütz, B., Roth, K. S., et al. (2013) · Alzheimer s Research & Therapy · doi:10.1186/alzrt158 · Cited by 68
Rieckmann, A., Dijk, K. R. A. V., Sperling, R. A., Johnson, K. A., Buckner, R. L., & Hedden, T. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.03.016 · Cited by 67
Dissociable Effects of Alzheimer Disease and White Matter Hyperintensities on Brain Metabolism
Haight, T. J. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.1878 · Cited by 65
Mallik, A. K., Drzezga, A. E., & Minoshima, S. (2016) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2016.09.005 · Cited by 64
Association of small vessel disease with tau pathology
Kapasi, A., Yu, L., Petyuk, V., Arfanakis, K., Bennett, D. A., & Schneider, J. A. (2022) · Acta Neuropathologica · doi:10.1007/s00401-021-02397-x · Cited by 55
Cardenas, V. A., Reed, B., Chao, L. L., Chui, H. C., Sanossian, N., DeCarli, C. S., Mack, W. J., Kramer, J. H., Hodis, H. N., Yan, M., et al. (2012) · Stroke · doi:10.1161/strokeaha.112.659722 · Cited by 55
Self-citationSchreiber, S., Drukarch, B., Garz, C., Niklass, S., Stanaszek, L., Kropf, S., Bueche, C. Z., Held, F., Vielhaber, S., Attems, J., et al. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132618 · Cited by 55
Xu, W., Xu, F., Anderson, M. E., Kotarba, A. E., Davis, J., Robinson, J. K., & Nostrand, W. E. V. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130758 · Cited by 52
Association of vascular brain injury, neurodegeneration, amyloid, and cognitive trajectory
Han, J. W., Maillard, P., Harvey, D., Fletcher, E., Martinez, O., Johnson, D. K., Olichney, J. M., Farias, S. T., Villeneuve, S., Jagust, W., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000010531 · Cited by 49
Self-citationThe role of cerebrovascular disease when there is concomitant Alzheimer disease
Vemuri, P., & Knopman, D. S. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.09.013 · Cited by 48
Interactions between vascular burden and amyloid-β pathology on trajectories of tau accumulation
Coomans, E. M., van Westen, D., Binette, A. P., Strandberg, O. T., Spotorno, N., Serrano, G. E., Beach, T. G., Palmqvist, S., Stomrud, E., Ossenkoppele, R., et al. (2023) · Brain · doi:10.1093/brain/awad317 · Cited by 47
Akinyemi, R., Allan, L. M., Oakley, A. E., & Kalaria, R. N. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00717 · Cited by 43
White Matter Hyperintensities are associated with Amyloid Burden in APOE4 Non-Carriers
Noh, Y., Seo, S. W., Jeon, S., Lee, J. M., Kim, J., Kim, G. H., Cho, H., Yoon, C. W., Kim, H. J., Ye, B. S., et al. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-130461 · Cited by 43
Self-citationCharacterizing a perfusion-based periventricular small vessel region of interest
Dolui, S., Tisdall, M. D., Vidorreta, M., Jacobs, D. R., Nasrallah, I. M., Bryan, R. N., Wolk, D. A., & Detre, J. A. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101897 · Cited by 43
White matter lesions may be an early marker for age-related cognitive decline
Morrison, C., Dadar, M., Villeneuve, S., Collins, D. L., & Initiative, A. D. N. (2022) · NeuroImage Clinical · doi:10.1016/j.nicl.2022.103096 · Cited by 40
Brain amyloid β, cerebral small vessel disease, and cognition
Saridin, F. N., Hilal, S., Villaraza, S., Reilhac, A., Gyanwali, B., Tanaka, T., Stephenson, M., Ng, S., Vrooman, H., van der Flier, W. M., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000011029 · Cited by 35
Is Cerebral Amyloid-β Deposition Related to Post-stroke Cognitive Impairment?
Ouyang, F., Jiang, Z., Chen, X., Chen, Y., Wei, J., Xing, S., Zhang, J., Fan, Y., & Zeng, J. (2021) · Translational Stroke Research · doi:10.1007/s12975-021-00921-5 · Cited by 41
Vemuri, P., DeCarli, C. S., & Duering, M. (2022) · Stroke · doi:10.1161/strokeaha.120.032611 · Cited by 46
Self-citationPositron Emission Tomographic Imaging in Stroke
Sahathevan, R., Linden, T. K. A., Villemagne, V. L., Churilov, L. P., Ly, J. V., Rowe, C. C., Donnan, G. A., & Brodtmann, A. G. (2015) · Stroke · doi:10.1161/strokeaha.115.010528 · Cited by 41
Cognitive function in patients with coronary artery disease: A literature review
Burkauskas, J., Lang, P., Bunevičius, A., Neverauskas, J., Bučiūtė-Jankauskienė, M., & Mickuvienė, N. (2018) · Journal of International Medical Research · doi:10.1177/0300060517751452 · Cited by 43
Guo, T., Dukart, J., Brendel, M., Rominger, A., Grimmer, T., Yakushev, I. Y., & Initiative, A. D. N. (2018) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.05.013 · Cited by 37
IMAGING VASCULAR DISEASE AND AMYLOID IN THE AGING BRAIN: IMPLICATIONS FOR TREATMENT
Villeneuve, S., & Jagust, W. J. (2015) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2015.47 · Cited by 32
Self-citationCerebral amyloidosis associated with cognitive decline in autosomal dominant Alzheimer disease
Wang, F., Gordon, B. A., Ryman, D. C., Ma, S., Xiong, C., Hassenstab, J. J., Goate, A., Fagan, A. M., Cairns, N. J., Marcus, D. S., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001903 · Cited by 34
DeCarli, C. S., Villeneuve, S., Maillard, P., Harvey, D. J., Singh, B., Carmichael, O. T., Fletcher, E. M., Olichney, J., Farias, S. T., Jagust, W. J., et al. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180965 · Cited by 33
Self-citationBurkauskas, J., Brožaitienė, J., Bunevičius, A., Neverauskas, J., Zaliunaite, V., & Bunevičius, R. (2016) · Cognitive and Behavioral Neurology · doi:10.1097/wnn.0000000000000093 · Cited by 35
“Alzheimer's disease” is neither “Alzheimer's clinical syndrome” nor “dementia”
Jagust, W. J., Jack, C. R., Bennett, D. A., Blennow, K., Haeberlein, S. B., Holtzman, D. M., Jessen, F., Karlawish, J. H., Liu, E., Molinuevo, J. L., et al. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.11.002 · Cited by 32
Self-citationLiu, H., Qiu, H., Xiao, Q., & Le, W. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150303 · Cited by 32
Kim, S. Y., & Cheon, J. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102446 · Cited by 33
Cerebral Amyloid-β Deposition Is Associated with Impaired Gait Speed and Lower Extremity Function
Dao, E. A., Hsiung, G. R., Sossi, V., Tam, R. C., Shahinfard, E., Nicklin, E., Alkeridy, W. A., & Liu-Ambrose, T. Y. L. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180848 · Cited by 31
Ourry, V., Binette, A. P., St‐Onge, F., Strikwerda‐Brown, C., Chagnot, A., Poirier, J., Breitner, J. C. S., Arenaza‐Urquijo, E. M., Rabin, J. S., Buckley, R. F., et al. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2023.09.003 · Cited by 30
Self-citationAdvances in Vascular Cognitive Impairment
Gorelick, P. B., & Pantoni, L. (2013) · Stroke · doi:10.1161/strokeaha.111.000219 · Cited by 29
Rieckmann, A., Hedden, T., Younger, A. P., Sperling, R. A., Johnson, K. A., & Buckner, R. L. (2015) · Human Brain Mapping · doi:10.1002/hbm.23054 · Cited by 28
Zhang, F., Zhong, R., Qi, H., Li, S., Cheng, C., Liu, X., Liu, Y., & Le, W. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00314 · Cited by 29
Reduced glucose uptake and Aβ in brain regions with hyperintensities in connected white matter
Glodzik, L., Kuceyeski, A. F., Rusinek, H., Tsui, W.-H., Mosconi, L., Li, Y., Osorio, R. S., Williams, S., Randall, C., Spector, N. C., et al. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2014.06.060 · Cited by 26
Amyloid burden and white matter hyperintensities mediate age-related cognitive differences
Dupont, P. S., Bocti, C., Joannette, M., Lavallée, M. M., Nikelski, J., Vallet, G. T., Chertkow, H., & Joubert, S. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.08.025 · Cited by 25
Shi, D., Xie, S., Li, A., Wang, Q., Guo, H., Han, Y., Xu, H., Gan, W., Zhang, L., Guo, T., et al. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01899-w · Cited by 25
Understanding and Treating Vascular Cognitive Impairment
Gorelick, P. B., & Nyenhuis, D. L. (2013) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000429174.29601.de · Cited by 25
Freeze, W. M., on behalf of the LeARN project, Jacobs, H. I. L., Gronenschild, E. H. B. M., Jansen, J. F. A., Burgmans, S., Aalten, P., Clerx, L., Vos, S. J. B., van Buchem, M. A., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160474 · Cited by 26
Plasma β-amyloid and MRI markers of cerebral small vessel disease
Kaffashian, S., Tzourio, C., Soumaré, A., Dufouil, C., Zhu, Y., Crivello, F., Maillard, P., Schraen‐Maschke, S., Mazoyer, B. M., Buée, L., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000001038 · Cited by 23
Zachariou, V., Pappas, C. A., Bauer, C. E., Shao, X., Liu, P., Lu, H., Wang, D. J. J., & Gold, B. T. (2023) · GeroScience · doi:10.1007/s11357-023-00930-2 · Cited by 21
The Impact of Amyloid-β or Tau on Cognitive Change in the Presence of Severe Cerebrovascular Disease
Jang, H., Initiative, A. D. N., Kim, H. J., Choe, Y. S., Kim, S.-J., Park, S., Kim, Y., Kim, K. W., Lyoo, C. H., Cho, H., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200680 · Cited by 20
Self-citationBilgel, M., Bannerjee, A., Shafer, A. T., An, Y., & Resnick, S. M. (2021) · Neuroimage Reports · doi:10.1016/j.ynirp.2021.100068 · Cited by 20
WMH Contributions to Cognitive Impairment: Rationale and Design of the Diverse VCID Study
DeCarli, C. S., Rajan, K. B., Jin, L., Hinman, J. D., Johnson, D. K., Harvey, D. J., Fornage, M., Beiser, A., Gonzalez, H., Kukull, W. A., et al. (2024) · Stroke · doi:10.1161/strokeaha.124.045903 · Cited by 20
Self-citationPreventing Vascular Effects on Brain Injury and Cognition Late in Life: Knowns and Unknowns
Carmichael, O. T. (2014) · Neuropsychology Review · doi:10.1007/s11065-014-9264-7 · Cited by 19
Ramos, A. R., Dib, S. I., & Wright, C. B. (2013) · Current Translational Geriatrics and Experimental Gerontology Reports · doi:10.1007/s13670-013-0054-5 · Cited by 21
Harrison, T. M., Ward, T. J., Taggett, J. Z., Maillard, P., Lockhart, S. N., Jung, Y., Lovato, L., Koeppe, R. A., Jagust, W. J., Harvey, D. J., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14399 · Cited by 16
Self-citationKocsis, P., Gyertyán, I., Éles, J., Laszy, J., Hegedűs, N., Gajári, D., Deli, L., Pozsgay, Z., Dávid, S., & Tihanyi, K. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.47 · Cited by 16
Ouyang, F., Chen, X., Chen, Y., Liang, J., Chen, Y., Lu, T., Huang, W., & Zeng, J. (2019) · Brain Pathology · doi:10.1111/bpa.12764 · Cited by 16
Twait, E. L., Min, B., Beran, M., Vonk, J. M. J., & Geerlings, M. I. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101952 · Cited by 15
Molecular Neuroimaging in Vascular Cognitive Impairment
Gurol, M. E. (2016) · Stroke · doi:10.1161/strokeaha.115.007958 · Cited by 15
Sachdev, P. S. (2020) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000577 · Cited by 13
White Matter Hyperintensity as a Vascular Contribution to the AT(N) Framework
Ng, K. P., shen, J., Chiew, H. J., Ng, A., Kandiah, N., Rosa‐Neto, P., & Gauthier, S. G. (2023) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2023.53 · Cited by 12
Cerebrovascular markers of WMH and infarcts in ADNI: A historical perspective and future directions
Maillard, P., Fletcher, E. M., Carmichael, O. T., Schwarz, C. G., Seiler, S., DeCarli, C. S., & Initiative, A. D. N. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14358 · Cited by 17
Self-citationLow Subicular Volume as an Indicator of Dementia-Risk Susceptibility in Old Age
Kagerer, S. M., Schroeder, C., Bergen, J. M. G. V., Schreiner, S. J., Meyer, R., Steininger, S. C., Vionnet, L., Gietl, A. F., Treyer, V., Buck, A., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.811146 · Cited by 14
Chang, Y. Z., Li, C., Yang, H., Wu, Y., Xu, B., Zhang, J., & Wang, R. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00745 · Cited by 14
Divergent functional connectivity changes associated with white matter hyperintensities
Santillo, A. F., Strandberg, T. O., Reislev, N. H., Nilsson, M., Stomrud, E., Spotorno, N., van Westen, D., & Hansson, O. (2024) · NeuroImage · doi:10.1016/j.neuroimage.2024.120672 · Cited by 12
Comorbidity of Cerebrovascular and Alzheimer’s Disease in Aging
Xia, Y., Yassi, N., Raniga, P., Bourgeat, P., Desmond, P. M., Doecke, J. D., Ames, D. J., Laws, S. M., Fowler, C. J., Rainey‐Smith, S. R., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200419 · Cited by 13
Johnson, M. L., Grazul‐Bilska, A. T., Reynolds, L. P., & Redmer, D. A. (2014) · Reproduction · doi:10.1530/rep-13-0548 · Cited by 11
The Orphan C2orf40 Gene is a Neuroimmune Factor in Alzheimer's Disease.
Podvin, S., Miller, M. C., Rossi, R., Chukwueke, J., Donahue, J. E., Johanson, C. E., Baird, A., & Stopa, E. G. (2016) · PubMed · Cited by 11
Ortega, G., Espinosa, A., Alegret, M., Monté, G. C., Sotolongo‐Grau, Ó., Sanabria, Á., Tartari, J. P., Rodríguez‐Gómez, O., Marquié, M., Vivas, A., et al. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00877-6 · Cited by 10
Comorbid amyloid‐β pathology affects clinical and imaging features in VCD
Leijenaar, J. F., Groot, C., Sudre, C. H., Bergeron, D., Leeuwis, A. E., Cardoso, M. J., Prados, F., Laforce, R. J., Barkhof, F., van der Flier, W. M., et al. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.08.190 · Cited by 10
Metadata
- Authors
- Marchant, N. L., Reed, B. R., DeCarli, C. S., Madison, C. M., Weiner, M. W., Chui, H. C., & Jagust, W. J.
- Affiliations
- Lawrence Berkeley National Laboratory (US)
- University of California, Davis (US)
- University of California, Berkeley (US)
- University of California, San Francisco (US)
- University of Southern California (US)
- Corresponding author
- Marchant, Natalie L.
- ORCID
- Venue
- Neurobiology of Aging
- Publisher
- Elsevier BV
- Published
- 2012-05
- Volume
- 33
- Issue
- 5
- Pages
- 1006.e25-1006.e36
- ISSN
- 0197-4580 (ISSN-L)
- PMC
- PMC3274647
- OpenAlex
- W1972661606
- Cited by
- 127
- References
- 86
- Citations by year
- 2025: 1 · 2024: 6 · 2023: 13 · 2022: 6 · 2021: 7 · 2020: 11 · 2019: 10 · 2018: 10 · 2017: 3 · 2016: 15 · 2015: 11 · 2014: 15 · 2013: 13 · 2012: 5
- FWCI
- 7.48
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Neurobiology of Aging (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- National Institutes of Health (AG012435, AG034570)
- Alzheimer's Association (ZEN-08-87090)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Cerebrovascular and genetic disorders
- Keywords
- cerebrovascular disease, amyloid-beta, cognitive aging, white matter hyperintensities, cerebral infarction, Pittsburgh compound B PET, executive function, episodic memory, normal aging, Alzheimer's disease
- MeSH terms
- Aged, Aged, 80 and over, Aging, Cerebrovascular Disorders, Cognition, Female, Humans, Male, Risk Factors, Cohort Studies, Amyloid beta-Peptides, Executive Function, Cognitive Dysfunction, Memory, Episodic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
